<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00907790</url>
  </required_header>
  <id_info>
    <org_study_id>32722</org_study_id>
    <secondary_id>2R01NR004142</secondary_id>
    <nct_id>NCT00907790</nct_id>
  </id_info>
  <brief_title>Nursing Management of Irritable Bowel Syndrome (IBS) 2008</brief_title>
  <official_title>Nursing Management of IBS:Improving Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is test the efficacy of a comprehensive self-management therapy to
      decrease abdominal pain/discomfort and improve quality of life in patients with irritable
      bowel syndrome (IBS) compared to IBS patients receiving their usual care.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Daily abdominal pain</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>IBS Quality of Life Questionnaire</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Salivary cortisol</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-10(IL-10) and Interleukin-12(IL-12)</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal calprotectin</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal permeability (urine)</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Symptom Inventory</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Scale for Functional Bowel Disorders</measure>
    <time_frame>Baseline three and six months post randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work Productivity &amp; Activity Impairment</measure>
    <time_frame>Baseline, three and six months post rand</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily symptoms(other GI and psychological)</measure>
    <time_frame>Baseline, three and six months post randomization</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Comprehensive Self-Management (CSM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Comprehensive Self-Management includes 8 sessions that cover education, diet, relaxation training, and cognitive behavioral strategies as they related to symptoms of IBS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care (Control Group)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Includes the usual care provided by the person and their health care provider.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual Care (Control Group)</intervention_name>
    <arm_group_label>Usual Care (Control Group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Comprehensive Self-Management (CSM)</intervention_name>
    <description>Comprehensive Self-Management includes 8 sessions that cover education, diet, relaxation training, and cognitive behavioral strategies as they related to symptoms of IBS</description>
    <arm_group_label>Comprehensive Self-Management (CSM)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women must be: 18-70 years old, have had symptoms of Irritable Bowel Syndrome
             (IBS) at least 6 mo prior to their diagnosis, and have had their diagnosis for at
             least 6 months, and the diagnosis had to be made by a health care provider (e.g.,
             internist, gastroenterologist, family, nurse practitioner, physician assistant).

          -  In addition, the subjects must be experiencing IBS symptoms as described in the
             Rome-III criteria.161 That is recurrent abdominal pain or discomfort at least 3 days a
             mo in the last 3 mo associated with 2 or more of the following: improvement with
             defecation, onset associated with a change in frequency or form (appearance) of their
             stool.

          -  Adults 50 or older must have a negative colonoscopy, sigmoidoscopy, abdominal
             ultrasonography, or barium enema.

          -  Anyone with a &quot;red flag&quot; symptom (e.g., lost 10 lbs without trying, blood in stool,
             anemia) will be contacted for additional clarification.

        Exclusion Criteria:

          -  Participants will be excluded if they are taking the following medications:
             antibiotics, daily use of anticholinergics, tricyclic antidepressants, calcium-channel
             blockers

          -  Have a medical history of abdominal surgery (except appendectomy, Caesarian section,
             tubal ligation, laparoscopic cholecystectomy, hysterectomy, or abdominal wall hernia
             repair)

          -  Active organic GI disease, gluten intolerance (celiac disease), or chronic moderate to
             severe pain condition (e.g., low back pain, fibromyalgia)

          -  Recent travel to regions with endemic parasitic diseases

          -  Current mental health disorders (psychosis, bipolar disorder, current moderate to
             severe depressive episode, suicide attempt, drug or alcohol abuse or dependence within
             2yrs)

          -  Cardiac valvular disease, immune compromised immunologic disorders (e.g., autoimmune
             conditions)

          -  Women who are pregnant, breast feeding, or planning to get pregnant in the next year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maargaret M Heitkemper, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2009</study_first_submitted>
  <study_first_submitted_qc>May 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2009</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Monica Jarrett</investigator_full_name>
    <investigator_title>Professor, Co-PI</investigator_title>
  </responsible_party>
  <keyword>Irritable Bowel Syndrome</keyword>
  <keyword>Cognitive Therapy</keyword>
  <keyword>Abdominal Pain</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

